Overview AV650 Drug-Drug Interaction Study Status: Completed Trial end date: 2007-05-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the effects that paroxetine and fluvoxamine have on the way the body distributes, breakdowns and eliminates AV650. In addition, information about any side effects that may occur will also be collected. Phase: Phase 1 Details Lead Sponsor: AvigenTreatments: FluvoxamineParoxetine